dissolving implant

The global implantable drug delivery devices market will grow by 8.8% by 2018 according to a new report from Transparency Market Research. Read more


In March 2013, the Evonik Birmingham Laboratories site received cGMP certification from the MHRA. The MHRA, a competent UK authority, conducted the audit on behalf of the EMA in the course of registering a new product called SCENESSE for the... Read more